| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 143.169 | 662.238 | 1.133.359 | 1.389.295 |
| Total Income - EUR | - | - | - | - | - | 0 | 143.173 | 663.584 | 1.134.305 | 1.391.370 |
| Total Expenses - EUR | - | - | - | - | - | 13.075 | 194.490 | 819.380 | 1.206.356 | 1.505.554 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -13.075 | -51.317 | -155.795 | -72.051 | -114.184 |
| Net Profit/Loss - EUR | - | - | - | - | - | -13.075 | -52.750 | -162.434 | -80.683 | -114.184 |
| Employees | - | - | - | - | - | 3 | 3 | 5 | 7 | 9 |
Check the financial reports for the company - Biscuit Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 991 | 1.276 | 651 | 1.031 | 526 |
| Current Assets | - | - | - | - | - | 1.346 | 230.365 | 514.658 | 867.057 | 1.087.087 |
| Inventories | - | - | - | - | - | 0 | 160.980 | 274.193 | 449.881 | 452.613 |
| Receivables | - | - | - | - | - | 1.218 | 62.460 | 235.430 | 385.277 | 519.071 |
| Cash | - | - | - | - | - | 129 | 6.924 | 5.035 | 31.899 | 115.403 |
| Shareholders Funds | - | - | - | - | - | -13.034 | -65.495 | -228.132 | -308.122 | -420.584 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 15.371 | 297.168 | 744.473 | 1.176.210 | 1.508.222 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Biscuit Pharma S.r.l.